Giant cell tumour of bone: morphological, biological and histogenetical aspects

被引:191
作者
Werner, Mathias [1 ]
机构
[1] Univ Hamburg, Hosp Eppendorf, Med Ctr, Inst Osteopathol, D-20246 Hamburg, Germany
关键词
D O I
10.1007/s00264-006-0215-7
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
The giant cell tumour of bone (GCT) is a locally aggressive intraosseous neoplasm of obscure biological behaviour. Although well defined in clinical, radiological and histological terms, detailed information on its biological development is still relatively incomplete. The tumoral tissue consists of three cell types - the neoplastic giant cell tumour stromal cells (GCTSC), representing the proliferative fraction, secondarily recruited mononuclear histiocytic cells (MNHC) and multinuclear giant cells (MNGC). These cellular components interact together with factors that have a role in regulating osteoclast function in normal bone tissue ( e. g. RANK, RANKL, OPG, M-CSF). Recent publications suggest that the neoplastic stromal cells express differentiation features of mesenchymal stem cells. Further research of the pathogenesis of GCT as well as the complex interactions of its cellular populations may provide the knowledge necessary for developing approaches for a biological-based therapy of this neoplasm.
引用
收藏
页码:484 / 489
页数:6
相关论文
共 65 条
[1]
Expression of osteoclast differentiation signals by stromal elements of giant cell tumors [J].
Atkins, GJ ;
Haynes, DR ;
Graves, SE ;
Evdokiou, A ;
Hay, S ;
Bouralexis, S ;
Findlay, DM .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (04) :640-649
[2]
Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone [J].
Atkins, GJ ;
Bouralexis, S ;
Haynes, DR ;
Graves, SE ;
Geary, SM ;
Evdokiou, A ;
Zannettino, ACW ;
Hay, S ;
Findlay, DM .
BONE, 2001, 28 (04) :370-377
[3]
CHROMOSOMAL-ABNORMALITIES IN GIANT-CELL TUMORS OF BONE [J].
BARDI, G ;
PANDIS, N ;
MANDAHL, N ;
HEIM, S ;
SFIKAS, K ;
WILLEN, H ;
PANAGIOTOPOULOS, G ;
RYDHOLM, A ;
MITELMAN, F .
CANCER GENETICS AND CYTOGENETICS, 1991, 57 (02) :161-167
[4]
BERTONI F, 1988, CLIN ORTHOP RELAT R, V237, P275
[5]
GIANT-CELL TUMOR OF BONE - CHROMOSOMAL ANALYSIS OF 48 SPECIMENS AND REVIEW OF THE LITERATURE [J].
BRIDGE, JA ;
NEFF, JR ;
MOURON, BJ .
CANCER GENETICS AND CYTOGENETICS, 1992, 58 (01) :2-13
[6]
BRIDGE JA, 1990, CANCER, V65, P2697, DOI 10.1002/1097-0142(19900615)65:12<2697::AID-CNCR2820651217>3.0.CO
[7]
2-3
[8]
Benign giant cell tumor of bone with osteosarcomatous transformation (''dedifferentiated'' primary malignant GCT): Report of two cases [J].
Brien, EW ;
Mirra, JM ;
Kessler, S ;
Suen, M ;
Ho, JKS ;
Yang, WT .
SKELETAL RADIOLOGY, 1997, 26 (04) :246-255
[9]
CAMPANACCI M, 1994, RECENT RESULTS CANC, V999, P257
[10]
Bisphosphonates may reduce recurrence in giant cell tumor by inducing apoptosis [J].
Chang, SS ;
Suratwala, SJ ;
Jung, KM ;
Doppelt, JD ;
Zhang, HZ ;
Blaine, TA ;
Kim, TW ;
Winchester, RJ ;
Lee, FYI .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2004, (426) :103-109